Trials / Completed
CompletedNCT03096223
A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis
A Phase 1, Open-Label, Multiple-Dose Study of KHK4083 in Subjects With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety and tolerability of multiple intravenous (IV) infusions of KHK4083 in subjects with moderate or severe atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHK4083 | IV administration |
Timeline
- Start date
- 2017-04-10
- Primary completion
- 2018-02-07
- Completion
- 2018-02-07
- First posted
- 2017-03-30
- Last updated
- 2018-03-27
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03096223. Inclusion in this directory is not an endorsement.